Innate Lymphoid Cells: Diversity, Plasticity, and Unique Functions in Immunity

Immunity

Volumn 48, Issue 6, 2018, Pages 1104-1117

  Colonna, Marco ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; CYTOKINE;

CELL COMPONENT; CELL INTERACTION; CELL PLASTICITY; CYTOKINE RELEASE; GENE EXPRESSION REGULATION; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOREGULATION; LYMPHOID CELL; MEMORY T LYMPHOCYTE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE;

ANIMALS; CELL DIFFERENTIATION; HUMANS; IMMUNITY, INNATE; LYMPHOCYTES;

EID: 85048628201     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2018.05.013     Document Type: Review

References (132)

1. Abdul-Aziz, M.A., Cooper, A., Weyrich, L.S., Exploring Relationships between Host Genome and Microbiome: New Insights from Genome-Wide Association Studies. Front. Microbiol., 7, 2016, 1611.
2. Allard, B., Longhi, M.S., Robson, S.C., Stagg, J., The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets. Immunol. Rev. 276 (2017), 121–144.
3. Bando, J.K., Colonna, M., Innate lymphoid cell function in the context of adaptive immunity. Nat. Immunol. 17 (2016), 783–789.
4. Bando, J.K., Gilfillan, S., Song, C., McDonald, K.G., Huang, S.C.-C., Newberry, R.D., Kobayashi, Y., Allan, D.S.J., Carlyle, J.R., Cella, M., Colonna, M., RANKL controls effector cytokine production in group 3 innate lymphoid cells. (2018). Immunity 48 (2018), 1208–1219 this issue.
5. Bank, U., Deiser, K., Finke, D., Hämmerling, G.J., Arnold, B., Schüler, T., Cutting edge: innate lymphoid cells suppress homeostatic T cell expansion in neonatal mice. J. Immunol. 196 (2016), 3532–3536.
6. Bar-Ephraïm, Y.E., Mebius, R.E., Innate lymphoid cells in secondary lymphoid organs. Immunol. Rev. 271 (2016), 185–199.
7. Barrow, A.D., Edeling, M.A., Trifonov, V., Luo, J., Goyal, P., Bohl, B., Bando, J.K., Kim, A.H., Walker, J., Andahazy, M., et al. Natural killer cells control tumor growth by sensing a growth factor. Cell 172 (2018), 534–548.e19.
8. Basu, R., O'Quinn, D.B., Silberger, D.J., Schoeb, T.R., Fouser, L., Ouyang, W., Hatton, R.D., Weaver, C.T., Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 37 (2012), 1061–1075.
9. Bernink, J.H., Peters, C.P., Munneke, M., te Velde, A.A., Meijer, S.L., Weijer, K., Hreggvidsdottir, H.S., Heinsbroek, S.E., Legrand, N., Buskens, C.J., et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat. Immunol. 14 (2013), 221–229.
10. Bernink, J.H., Krabbendam, L., Germar, K., de Jong, E., Gronke, K., Kofoed-Nielsen, M., Munneke, J.M., Hazenberg, M.D., Villaudy, J., Buskens, C.J., et al. Interleukin-12 and −23 control plasticity of CD127(+) group 1 and group 3 innate lymphoid cells in the intestinal lamina propria. Immunity 43 (2015), 146–160.
11. Björklund, A.K., Forkel, M., Picelli, S., Konya, V., Theorell, J., Friberg, D., Sandberg, R., Mjösberg, J., The heterogeneity of human CD127(+) innate lymphoid cells revealed by single-cell RNA sequencing. Nat. Immunol. 17 (2016), 451–460.
12. Cai, T., Qiu, J., Ji, Y., Li, W., Ding, Z., Suo, C., Chang, J., Wang, J., He, R., Qian, Y., et al. IL-17-producing-ST2(+)ILC2 plays a pathogenic role in lung inflammation. J Allergy Clin Immunol., 2018, 10.1016/j.jaci.2018.03.007 Published online April 3, 2018.
13. Cardoso, V., Chesné J., Ribeiro, H., García-Cassani, B., Carvalho, T., Bouchery, T., Shah, K., Barbosa-Morais, N.L., Harris, N., Veiga-Fernandes, H., Neuronal regulation of type 2 innate lymphoid cells via neuromedin U. Nature 549 (2017), 277–281.
14. Cella, M., Fuchs, A., Vermi, W., Facchetti, F., Otero, K., Lennerz, J.K., Doherty, J.M., Mills, J.C., Colonna, M., A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457 (2009), 722–725.
15. Cella, M., Otero, K., Colonna, M., Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity. Proc. Natl. Acad. Sci. USA 107 (2010), 10961–10966.
16. Chea, S., Perchet, T., Petit, M., Verrier, T., Guy-Grand, D., Banchi, E.G., Vosshenrich, C.A., Di Santo, J.P., Cumano, A., Golub, R., Notch signaling in group 3 innate lymphoid cells modulates their plasticity. Sci. Signal., 9, 2016, ra45.
17. Choi, S.C., Simhadri, V.R., Tian, L., Gil-Krzewska, A., Krzewski, K., Borrego, F., Coligan, J.E., Cutting edge: mouse CD300f (CMRF-35-like molecule-1) recognizes outer membrane-exposed phosphatidylserine and can promote phagocytosis. J. Immunol. 187 (2011), 3483–3487.
18. Constantinides, M.G., McDonald, B.D., Verhoef, P.A., Bendelac, A., A committed precursor to innate lymphoid cells. Nature 508 (2014), 397–401.
19. Cooper, M.A., Fehniger, T.A., Colonna, M., Is there natural killer cell memory and can it be harnessed by vaccination? Vaccination strategies based on NK cell and ILC memory. Cold Spring Harb Perspect Biol., 2017, 10.1101/cshperspect.a029512 Published online December 18, 2017.
20. Cortez, V.S., Cervantes-Barragan, L., Robinette, M.L., Bando, J.K., Wang, Y., Geiger, T.L., Gilfillan, S., Fuchs, A., Vivier, E., Sun, J.C., et al. Transforming growth factor-beta signaling guides the differentiation of innate lymphoid cells in salivary glands. Immunity 44 (2016), 1127–1139.
21. Cortez, V.S., Ulland, T.K., Cervantes-Barragan, L., Bando, J.K., Robinette, M.L., Wang, Q., White, A.J., Gilfillan, S., Cella, M., Colonna, M., SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-β signaling. Nat. Immunol. 18 (2017), 995–1003.
22. Dadi, S., Chhangawala, S., Whitlock, B.M., Franklin, R.A., Luo, C.T., Oh, S.A., Toure, A., Pritykin, Y., Huse, M., Leslie, C.S., Li, M.O., Cancer immunosurveillance by tissue-resident innate lymphoid cells and innate-like T cells. Cell 164 (2016), 365–377.
23. Dalli, J., Colas, R.A., Arnardottir, H., Serhan, C.N., Vagal regulation of group 3 innate lymphoid cells and the immunoresolvent PCTR1 controls infection resolution. Immunity 46 (2017), 92–105.
24. Daussy, C., Faure, F., Mayol, K., Viel, S., Gasteiger, G., Charrier, E., Bienvenu, J., Henry, T., Debien, E., Hasan, U.A., et al. T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. J. Exp. Med. 211 (2014), 563–577.
25. Diefenbach, A., Colonna, M., Koyasu, S., Development, differentiation, and diversity of innate lymphoid cells. Immunity 41 (2014), 354–365.
26. Doherty, T.A., Khorram, N., Lund, S., Mehta, A.K., Croft, M., Broide, D.H., Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production. J. Allergy Clin. Immunol. 132 (2013), 205–213.
27. Duerr, C.U., McCarthy, C.D., Mindt, B.C., Rubio, M., Meli, A.P., Pothlichet, J., Eva, M.M., Gauchat, J.F., Qureshi, S.T., Mazer, B.D., et al. Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells. Nat. Immunol. 17 (2016), 65–75.
28. DuPage, M., Bluestone, J.A., Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease. Nat. Rev. Immunol. 16 (2016), 149–163.
29. Eberl, G., Colonna, M., Di Santo, J.P., McKenzie, A.N., Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology. Science, 348, 2015, aaa6566.
30. Ebihara, T., Song, C., Ryu, S.H., Plougastel-Douglas, B., Yang, L., Levanon, D., Groner, Y., Bern, M.D., Stappenbeck, T.S., Colonna, M., et al. Runx3 specifies lineage commitment of innate lymphoid cells. Nat. Immunol. 16 (2015), 1124–1133.
31. Ellinghaus, D., Bethune, J., Petersen, B.S., Franke, A., The genetics of Crohn's disease and ulcerative colitis–status quo and beyond. Scand. J. Gastroenterol. 50 (2015), 13–23.
32. Ishigaki, K., Kochi, Y., Yamamoto, K., Genetics of human autoimmunity: From genetic information to functional insights. Clin. Immunol. 186 (2018), 9–13.
33. Emgård, J., Kammoun, H., García-Cassani, B., Chesné J., Parigi, S.M., Jacob, J.M., Cheng, H.W., Evren, E., Das, S., Czarnewski, P., et al. Oxysterol sensing through the receptor GPR183 promotes the lymphoid-tissue-inducing function of innate lymphoid cells and colonic inflammation. Immunity 48 (2018), 120–132.e8.
34. Freud, A.G., Mundy-Bosse, B.L., Yu, J., Caligiuri, M.A., The broad spectrum of human natural killer cell diversity. Immunity 47 (2017), 820–833.
35. Fuchs, A., Vermi, W., Lee, J.S., Lonardi, S., Gilfillan, S., Newberry, R.D., Cella, M., Colonna, M., Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells. Immunity 38 (2013), 769–781.
36. Gao, Y., Souza-Fonseca-Guimaraes, F., Bald, T., Ng, S.S., Young, A., Ngiow, S.F., Rautela, J., Straube, J., Waddell, N., Blake, S.J., et al. Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells. Nat. Immunol. 18 (2017), 1004–1015.
37. Gasteiger, G., Fan, X., Dikiy, S., Lee, S.Y., Rudensky, A.Y., Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs. Science 350 (2015), 981–985.
38. Gebhardt, T., Palendira, U., Tscharke, D.C., Bedoui, S., Tissue-resident memory T cells in tissue homeostasis, persistent infection, and cancer surveillance. Immunol. Rev. 283 (2018), 54–76.
39. Ginhoux, F., Jung, S., Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat. Rev. Immunol. 14 (2014), 392–404.
40. Glatzer, T., Killig, M., Meisig, J., Ommert, I., Luetke-Eversloh, M., Babic, M., Paclik, D., Bluthgen, N., Seidl, R., Seifarth, C., et al. RORgammat(+) innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44. Immunity 38 (2013), 1223–1235.
41. Guo, X., Liang, Y., Zhang, Y., Lasorella, A., Kee, B.L., Fu, Y.X., Innate Lymphoid Cells Control Early Colonization Resistance against Intestinal Pathogens through ID2-Dependent Regulation of the Microbiota. Immunity 42 (2015), 731–743.
42. Gury-BenAri, M., Thaiss, C.A., Serafini, N., Winter, D.R., Giladi, A., Lara-Astiaso, D., Levy, M., Salame, T.M., Weiner, A., David, E., et al. The spectrum and regulatory landscape of intestinal innate lymphoid cells are shaped by the microbiome. Cell 166 (2016), 1231–1246.e13.
43. Hayakawa, Y., Huntington, N.D., Nutt, S.L., Smyth, M.J., Functional subsets of mouse natural killer cells. Immunol. Rev. 214 (2006), 47–55.
44. Hepworth, M.R., Monticelli, L.A., Fung, T.C., Ziegler, C.G., Grunberg, S., Sinha, R., Mantegazza, A.R., Ma, H.L., Crawford, A., Angelosanto, J.M., et al. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 498 (2013), 113–117.
45. Holmes, T.D., Bryceson, Y.T., Natural killer cell memory in context. Semin. Immunol. 28 (2016), 368–376.
46. Honda, K., Littman, D.R., The microbiota in adaptive immune homeostasis and disease. Nature 535 (2016), 75–84.
47. Huang, Y., Guo, L., Qiu, J., Chen, X., Hu-Li, J., Siebenlist, U., Williamson, P.R., Urban, J.F. Jr., Paul, W.E., IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential ‘inflammatory’ type 2 innate lymphoid cells. Nat. Immunol. 16 (2015), 161–169.
48. Huang, Y., Mao, K., Chen, X., Sun, M.A., Kawabe, T., Li, W., Usher, N., Zhu, J., Urban, J.F. Jr., Paul, W.E., Germain, R.N., S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense. Science 359 (2018), 114–119.
49. Huntington, N.D., Carpentier, S., Vivier, E., Belz, G.T., Innate lymphoid cells: parallel checkpoints and coordinate interactions with T cells. Curr. Opin. Immunol. 38 (2016), 86–93.
50. Ibiza, S., García-Cassani, B., Ribeiro, H., Carvalho, T., Almeida, L., Marques, R., Misic, A.M., Bartow-McKenney, C., Larson, D.M., Pavan, W.J., et al. Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence. Nature 535 (2016), 440–443.
51. Jameson, S.C., Masopust, D., Understanding subset diversity in T cell memory. Immunity 48 (2018), 214–226.
52. Johnson, J.L., Vahedi, G., Do Memory CD4 T Cells Keep Their Cell-Type Programming: Plasticity versus Fate Commitment? Epigenome: a dynamic vehicle for transmitting and recording cytokine signaling. Cold Spring Harb. Perspect. Biol., 10, 2018, 10.
53. Jonkers, I.H., Wijmenga, C., Context-specific effects of genetic variants associated with autoimmune disease. Hum. Mol. Genet. 26 (2017), R185–R192.
54. Kamili, Q.U.A., Seeborg, F.O., Saxena, K., Nicholas, S.K., Banerjee, P.P., Angelo, L.S., Mace, E.M., Forbes, L.R., Martinez, C., Wright, T.S., et al. Severe cutaneous human papillomavirus infection associated with natural killer cell deficiency following stem cell transplantation for severe combined immunodeficiency. J. Allergy Clin. Immunol. 134 (2014), 1451–1453.e1.
55. Klose, C.S., Artis, D., Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. Nat. Immunol. 17 (2016), 765–774.
56. Klose, C.S., Kiss, E.A., Schwierzeck, V., Ebert, K., Hoyler, T., d'Hargues, Y., Göppert, N., Croxford, A.L., Waisman, A., Tanriver, Y., Diefenbach, A., A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells. Nature 494 (2013), 261–265.
57. Klose, C.S.N., Flach, M., Möhle, L., Rogell, L., Hoyler, T., Ebert, K., Fabiunke, C., Pfeifer, D., Sexl, V., Fonseca-Pereira, D., et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157 (2014), 340–356.
58. Klose, C.S.N., Mahlakõiv, T., Moeller, J.B., Rankin, L.C., Flamar, A.L., Kabata, H., Monticelli, L.A., Moriyama, S., Putzel, G.G., Rakhilin, N., et al. The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation. Nature 549 (2017), 282–286.
59. Kløverpris, H.N., Kazer, S.W., Mjösberg, J., Mabuka, J.M., Wellmann, A., Ndhlovu, Z., Yadon, M.C., Nhamoyebonde, S., Muenchhoff, M., Simoni, Y., et al. Innate lymphoid cells are depleted irreversibly during acute HIV-1 infection in the absence of viral suppression. Immunity 44 (2016), 391–405.
60. Koues, O.I., Collins, P.L., Cella, M., Robinette, M.L., Porter, S.I., Pyfrom, S.C., Payton, J.E., Colonna, M., Oltz, E.M., Distinct gene regulatory pathways for human innate versus adaptive lymphoid cells. Cell 165 (2016), 1134–1146.
61. Koyasu, S., Moro, K., Tanabe, M., Takeuchi, T., Natural helper cells: a new player in the innate immune response against helminth infection. Adv. Immunol. 108 (2010), 21–44.
62. Langlais, D., Fodil, N., Gros, P., Genetics of Infectious and Inflammatory Diseases: Overlapping Discoveries from Association and Exome-Sequencing Studies. Annu. Rev. Immunol. 35 (2017), 1–30.
63. Lee, S.H., Kim, K.S., Fodil-Cornu, N., Vidal, S.M., Biron, C.A., Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection. J. Exp. Med. 206 (2009), 2235–2251.
64. Lee, J.S., Cella, M., McDonald, K.G., Garlanda, C., Kennedy, G.D., Nukaya, M., Mantovani, A., Kopan, R., Bradfield, C.A., Newberry, R.D., Colonna, M., AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 13 (2011), 144–151.
65. Lee, Y.J., Holzapfel, K.L., Zhu, J., Jameson, S.C., Hogquist, K.A., Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat. Immunol. 14 (2013), 1146–1154.
66. Lee, Y.J., Starrett, G.J., Lee, S.T., Yang, R., Henzler, C.M., Jameson, S.C., Hogquist, K.A., Lineage-specific effector signatures of invariant NKT cells are shared amongst gammadelta T, innate lymphoid, and Th cells. J. Immunol. 197 (2016), 1460–1470.
67. Li, S., Bostick, J.W., Zhou, L., Regulation of Innate Lymphoid Cells by Aryl Hydrocarbon Receptor. Front. Immunol., 8, 2018, 1909.
68. Lim, A.I., Menegatti, S., Bustamante, J., Le Bourhis, L., Allez, M., Rogge, L., Casanova, J.L., Yssel, H., Di Santo, J.P., IL-12 drives functional plasticity of human group 2 innate lymphoid cells. J. Exp. Med. 213 (2016), 569–583.
69. Lim, A.I., Li, Y., Lopez-Lastra, S., Stadhouders, R., Paul, F., Casrouge, A., Serafini, N., Puel, A., Bustamante, J., Surace, L., et al. Systemic human ILC precursors provide a substrate for tissue ILC differentiation. Cell 168 (2017), 1086–1100.e10.
70. Liu, T.C., Stappenbeck, T.S., Genetics and Pathogenesis of Inflammatory Bowel Disease. Annu. Rev. Pathol. 11 (2016), 127–148.
71. Loza, M.J., Perussia, B., Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation?. Nat. Immunol. 2 (2001), 917–924.
72. Mace, E.M., Orange, J.S., Genetic causes of human NK cell deficiency and their effect on NK cell subsets. Front. Immunol., 7, 2016, 545.
73. Mackay, L.K., Minnich, M., Kragten, N.A., Liao, Y., Nota, B., Seillet, C., Zaid, A., Man, K., Preston, S., Freestone, D., et al. Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes. Science 352 (2016), 459–463.
74. Mao, K., Baptista, A.P., Tamoutounour, S., Zhuang, L., Bouladoux, N., Martins, A.J., Huang, Y., Gerner, M.Y., Belkaid, Y., Germain, R.N., Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism. Nature 554 (2018), 255–259.
75. 2 suppresses human group 2 innate lymphoid cell function. J. Allergy Clin. Immunol. 141 (2018), 1761–1773.e6.
76. Martin, C.E., Spasova, D.S., Frimpong-Boateng, K., Kim, H.O., Lee, M., Kim, K.S., Surh, C.D., Interleukin-7 availability is maintained by a hematopoietic cytokine sink comprising innate lymphoid cells and T cells. Immunity 47 (2017), 171–182.e4.
77. Martinez-Gonzalez, I., Mathä L., Steer, C.A., Ghaedi, M., Poon, G.F., Takei, F., Allergen-experienced group 2 innate lymphoid cells acquire memory-like properties and enhance allergic lung inflammation. Immunity 45 (2016), 198–208.
78. McGovern, D.P., Kugathasan, S., Cho, J.H., Genetics of Inflammatory Bowel Diseases. Gastroenterology 149 (2015), 1163–1176 e1162.
79. Mikami, Y., Scarno, G., Zitti, B., Shih, H.Y., Kanno, Y., Santoni, A., O'Shea, J.J., Sciume, G., NCR(+) ILC3 maintain larger STAT4 reservoir via T-BET to regulate type 1 features upon IL-23 stimulation in mice. Eur. J. Immunol., 2018 doi: 10.1002.
80. + T cells. Curr. Opin. Immunol. 51 (2018), 162–169.
81. Mjösberg, J.M., Trifari, S., Crellin, N.K., Peters, C.P., van Drunen, C.M., Piet, B., Fokkens, W.J., Cupedo, T., Spits, H., Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat. Immunol. 12 (2011), 1055–1062.
82. Molofsky, A.B., Van Gool, F., Liang, H.E., Van Dyken, S.J., Nussbaum, J.C., Lee, J., Bluestone, J.A., Locksley, R.M., Interleukin-33 and Interferon-gamma Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation. Immunity 43 (2015), 161–174.
83. 2-adrenergic receptor-mediated negative regulation of group 2 innate lymphoid cell responses. Science 359 (2018), 1056–1061.
84. Moro, K., Kabata, H., Tanabe, M., Koga, S., Takeno, N., Mochizuki, M., Fukunaga, K., Asano, K., Betsuyaku, T., Koyasu, S., Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses. Nat. Immunol. 17 (2016), 76–86.
85. Moura-Alves, P., Faé K., Houthuys, E., Dorhoi, A., Kreuchwig, A., Furkert, J., Barison, N., Diehl, A., Munder, A., Constant, P., et al. AhR sensing of bacterial pigments regulates antibacterial defence. Nature 512 (2014), 387–392.
86. Narni-Mancinelli, E., Gauthier, L., Baratin, M., Guia, S., Fenis, A., Deghmane, A.E., Rossi, B., Fourquet, P., Escalière, B., Kerdiles, Y.M., et al. Complement factor P is a ligand for the natural killer cell-activating receptor NKp46. Sci. Immunol., 2, 2017, eaam9628.
87. Neill, D.R., Wong, S.H., Bellosi, A., Flynn, R.J., Daly, M., Langford, T.K., Bucks, C., Kane, C.M., Fallon, P.G., Pannell, R., et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464 (2010), 1367–1370.
88. Nussbaum, J.C., Van Dyken, S.J., von Moltke, J., Cheng, L.E., Mohapatra, A., Molofsky, A.B., Thornton, E.E., Krummel, M.F., Chawla, A., Liang, H.E., Locksley, R.M., Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 502 (2013), 245–248.
89. O'Sullivan, T.E., Rapp, M., Fan, X., Weizman, O.E., Bhardwaj, P., Adams, N.M., Walzer, T., Dannenberg, A.J., Sun, J.C., Adipose-resident group 1 innate lymphoid cells promote obesity-associated insulin resistance. Immunity 45 (2016), 428–441.
90. Ohne, Y., Silver, J.S., Thompson-Snipes, L., Collet, M.A., Blanck, J.P., Cantarel, B.L., Copenhaver, A.M., Humbles, A.A., Liu, Y.J., IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity. Nat. Immunol. 17 (2016), 646–655.
91. Oliphant, C.J., Hwang, Y.Y., Walker, J.A., Salimi, M., Wong, S.H., Brewer, J.M., Englezakis, A., Barlow, J.L., Hams, E., Scanlon, S.T., et al. MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity 41 (2014), 283–295.
92. Pavlov, V.A., Tracey, K.J., The vagus nerve and the inflammatory reflex–linking immunity and metabolism. Nat. Rev. Endocrinol. 8 (2012), 743–754.
93. Peng, H., Jiang, X., Chen, Y., Sojka, D.K., Wei, H., Gao, X., Sun, R., Yokoyama, W.M., Tian, Z., Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. J. Clin. Invest. 123 (2013), 1444–1456.
94. Pikovskaya, O., Chaix, J., Rothman, N.J., Collins, A., Chen, Y.H., Scipioni, A.M., Vivier, E., Reiner, S.L., Cutting edge: eomesodermin is sufficient to direct type 1 innate lymphocyte development into the conventional NK lineage. J. Immunol. 196 (2016), 1449–1454.
95. Post, M., Cuapio, A., Osl, M., Lehmann, D., Resch, U., Davies, D.M., Bilban, M., Schlechta, B., Eppel, W., Nathwani, A., et al. The transcription factor ZNF683/HOBIT regulates human NK-cell development. Front. Immunol., 8, 2017, 535.
96. Price, A.E., Liang, H.E., Sullivan, B.M., Reinhardt, R.L., Eisley, C.J., Erle, D.J., Locksley, R.M., Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc. Natl. Acad. Sci. USA 107 (2010), 11489–11494.
97. Qiu, J., Guo, X., Chen, Z.M., He, L., Sonnenberg, G.F., Artis, D., Fu, Y.X., Zhou, L., Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. Immunity 39 (2013), 386–399.
98. Rankin, L.C., Groom, J.R., Chopin, M., Herold, M.J., Walker, J.A., Mielke, L.A., McKenzie, A.N., Carotta, S., Nutt, S.L., Belz, G.T., The transcription factor T-bet is essential for the development of NKp46+ innate lymphocytes via the Notch pathway. Nat. Immunol. 14 (2013), 389–395.
99. Rauber, S., Luber, M., Weber, S., Maul, L., Soare, A., Wohlfahrt, T., Lin, N.Y., Dietel, K., Bozec, A., Herrmann, M., et al. Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells. Nat. Med. 23 (2017), 938–944.
100. Roan, F., Stoklasek, T.A., Whalen, E., Molitor, J.A., Bluestone, J.A., Buckner, J.H., Ziegler, S.F., CD4+ Group 1 innate lymphoid cells (ILC) form a functionally distinct ILC subset that is increased in systemic sclerosis. J. Immunol. 196 (2016), 2051–2062.
101. Robinette, M.L., Cella, M., Telliez, J.B., Ulland, T.K., Barrow, A.D., Capuder, K., Gilfillan, S., Lin, L.L., Notarangelo, L.D., Colonna, M., Jak3 deficiency blocks innate lymphoid cell development. Mucosal Immunol. 11 (2018), 50–60.
102. Sawa, S., Cherrier, M., Lochner, M., Satoh-Takayama, N., Fehling, H.J., Langa, F., Di Santo, J.P., Eberl, G., Lineage relationship analysis of RORgammat+ innate lymphoid cells. Science 330 (2010), 665–669.
103. Schuster, I.S., Wikstrom, M.E., Brizard, G., Coudert, J.D., Estcourt, M.J., Manzur, M., O'Reilly, L.A., Smyth, M.J., Trapani, J.A., Hill, G.R., et al. TRAIL+ NK cells control CD4+ T cell responses during chronic viral infection to limit autoimmunity. Immunity 41 (2014), 646–656.
104. Sciumé G., Hirahara, K., Takahashi, H., Laurence, A., Villarino, A.V., Singleton, K.L., Spencer, S.P., Wilhelm, C., Poholek, A.C., Vahedi, G., et al. Distinct requirements for T-bet in gut innate lymphoid cells. J. Exp. Med. 209 (2012), 2331–2338.
105. Seehus, C.R., Kadavallore, A., Torre, B., Yeckes, A.R., Wang, Y., Tang, J., Kaye, J., Alternative activation generates IL-10 producing type 2 innate lymphoid cells. Nat. Commun., 8, 2017, 1900.
106. Shih, H.Y., Sciumè G., Mikami, Y., Guo, L., Sun, H.W., Brooks, S.R., Urban, J.F. Jr., Davis, F.P., Kanno, Y., O'Shea, J.J., Developmental acquisition of regulomes underlies innate lymphoid cell functionality. Cell 165 (2016), 1120–1133.
107. Shin, J.H., Zhang, L., Murillo-Sauca, O., Kim, J., Kohrt, H.E., Bui, J.D., Sunwoo, J.B., Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. USA 110 (2013), 12391–12396.
108. Silver, J.S., Kearley, J., Copenhaver, A.M., Sanden, C., Mori, M., Yu, L., Pritchard, G.H., Berlin, A.A., Hunter, C.A., Bowler, R., et al. Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs. Nat. Immunol. 17 (2016), 626–635.
109. Simoni, Y., Fehlings, M., Kløverpris, H.N., McGovern, N., Koo, S.L., Loh, C.Y., Lim, S., Kurioka, A., Fergusson, J.R., Tang, C.L., et al. Human innate lymphoid cell subsets possess tissue-type based heterogeneity in phenotype and frequency. Immunity 46 (2017), 148–161.
110. Skon, C.N., Lee, J.Y., Anderson, K.G., Masopust, D., Hogquist, K.A., Jameson, S.C., Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells. Nat. Immunol. 14 (2013), 1285–1293.
111. Song, C., Lee, J.S., Gilfillan, S., Robinette, M.L., Newberry, R.D., Stappenbeck, T.S., Mack, M., Cella, M., Colonna, M., Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation. J. Exp. Med. 212 (2015), 1869–1882.
112. Spits, H., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J.P., Eberl, G., Koyasu, S., Locksley, R.M., McKenzie, A.N., Mebius, R.E., et al. Innate lymphoid cells–a proposal for uniform nomenclature. Nat. Rev. Immunol. 13 (2013), 145–149.
113. Stockinger, B., Di Meglio, P., Gialitakis, M., Duarte, J.H., The aryl hydrocarbon receptor: multitasking in the immune system. Annu. Rev. Immunol. 32 (2014), 403–432.
114. + group 2 innate lymphoid cells. J. Exp. Med. 214 (2017), 1663–1678.
115. Van Dyken, S.J., Nussbaum, J.C., Lee, J., Molofsky, A.B., Liang, H.E., Pollack, J.L., Gate, R.E., Haliburton, G.E., Ye, C.J., Marson, A., et al. A tissue checkpoint regulates type 2 immunity. Nat. Immunol. 17 (2016), 1381–1387.
116. Vély, F., Barlogis, V., Vallentin, B., Neven, B., Piperoglou, C., Ebbo, M., Perchet, T., Petit, M., Yessaad, N., Touzot, F., et al. Evidence of innate lymphoid cell redundancy in humans. Nat. Immunol. 17 (2016), 1291–1299.
117. Viant, C., Rankin, L.C., Girard-Madoux, M.J., Seillet, C., Shi, W., Smyth, M.J., Bartholin, L., Walzer, T., Huntington, N.D., Vivier, E., Belz, G.T., Transforming growth factor-β and Notch ligands act as opposing environmental cues in regulating the plasticity of type 3 innate lymphoid cells. Sci. Signal., 9, 2016, ra46.
118. Villanova, F., Flutter, B., Tosi, I., Grys, K., Sreeneebus, H., Perera, G.K., Chapman, A., Smith, C.H., Di Meglio, P., Nestle, F.O., Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis. J. Invest. Dermatol. 134 (2014), 984–991.
119. von Moltke, J., O'Leary, C.E., Barrett, N.A., Kanaoka, Y., Austen, K.F., Locksley, R.M., Leukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s. J. Exp. Med. 214 (2017), 27–37.
120. Vonarbourg, C., Mortha, A., Bui, V.L., Hernandez, P.P., Kiss, E.A., Hoyler, T., Flach, M., Bengsch, B., Thimme, R., Hölscher, C., et al. Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes. Immunity 33 (2010), 736–751.
121. Vosshenrich, C.A., García-Ojeda, M.E., Samson-Villéger, S.I., Pasqualetto, V., Enault, L., Richard-Le Goff, O., Corcuff, E., Guy-Grand, D., Rocha, B., Cumano, A., et al. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat. Immunol. 7 (2006), 1217–1224.
122. Wallrapp, A., Riesenfeld, S.J., Burkett, P.R., Abdulnour, R.E., Nyman, J., Dionne, D., Hofree, M., Cuoco, M.S., Rodman, C., Farouq, D., et al. The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation. Nature 549 (2017), 351–356.
123. Walsh, M.C., Choi, Y., Biology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond. Front. Immunol., 5, 2014, 511.
124. Wang, S., Xia, P., Chen, Y., Qu, Y., Xiong, Z., Ye, B., Du, Y., Tian, Y., Yin, Z., Xu, Z., Fan, Z., Regulatory innate lymphoid cells control innate intestinal inflammation. Cell 171 (2017), 201–216.e18.
125. Wang, Y., Gellatly, K., Derr, A., and Jaiswal, S. Kucukural, A., McDonel, P., Greenough, T., Houghton, JM., Garber, M., Luban J. HIV-1 unmasks the plasticity of innate lymphoid cells. (2018). BioRxiv. https://doi.org/10.1101/221010.
126. Waterfield, M.D., Scrace, G.T., Whittle, N., Stroobant, P., Johnsson, A., Wasteson, A., Westermark, B., Heldin, C.H., Huang, J.S., Deuel, T.F., Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature 304 (1983), 35–39.
127. Weizman, O.E., Adams, N.M., Schuster, I.S., Krishna, C., Pritykin, Y., Lau, C., Degli-Esposti, M.A., Leslie, C.S., Sun, J.C., O'Sullivan, T.E., ILC1 confer early host protection at initial sites of viral infection. Cell 171 (2017), 795–808.e12.
128. Xue, L., Salimi, M., Panse, I., Mjösberg, J.M., McKenzie, A.N., Spits, H., Klenerman, P., Ogg, G., Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. J. Allergy Clin. Immunol. 133 (2014), 1184–1194.
129. hi ILC progenitor and defines its development pathway. Nature 539 (2016), 102–106.
130. Zelante, T., Iannitti, R.G., Cunha, C., De Luca, A., Giovannini, G., Pieraccini, G., Zecchi, R., D'Angelo, C., Massi-Benedetti, C., Fallarino, F., et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39 (2013), 372–385.
131. Zhang, K., Xu, X., Pasha, M.A., Siebel, C.W., Costello, A., Haczku, A., MacNamara, K., Liang, T., Zhu, J., Bhandoola, A., et al. Cutting edge: notch signaling promotes the plasticity of group-2 innate lymphoid cells. J. Immunol. 198 (2017), 1798–1803.
132. Zook, E.C., Ramirez, K., Guo, X., van der Voort, G., Sigvardsson, M., Svensson, E.C., Fu, Y.X., Kee, B.L., The ETS1 transcription factor is required for the development and cytokine-induced expansion of ILC2. J. Exp. Med. 213 (2016), 687–696.